Media News

Medigen’s MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv). Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included...

Elekta receives initial investment grade rating from S&P Global Ratings

STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta and to the Group's senior unsecured notes, with stable outlook. S&P notes that Elekta's rating reflects the global leading position, ability to introduce new innovative treatment solutions...

Introducing Prodigy for Improved Peptide Purification

-- Improved resolution and separation of peptide impurities -- Easier purification of hydrophobic peptides -- Direct transfer from analytical to preparative scale MATTHEWS, N.C., Oct. 26, 2021 /PRNewswire/ -- CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-Performance Liquid Chromatography (HPLC) system. Key to the system is...

I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China

I-Mab strategic partnership with Sinopharm will covers all aspects of the go-to-market process, including authorization of more than 300 Sinopharm's subsidiaries as distributors across China. I-Mab is on track to submit BLA for third line multiple myeloma (MM) treatment by Q4 2021. The partnership underscores I-Mab overall vision and...

Qilian International Holding Group Limited Completes Phase One of Its Expansion of New Organic Fertilizer Production Facility and Puts It into Production

JIUQUAN, China, Oct. 26, 2021 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company"), a China-based pharmaceutical and chemical products manufacturer, today announced that the Company has completed phase one of the expansion of its new organic fertilizer production facility. As a result, the Company's annual production capacity of organic fertilizers has increased to 30,000 tons. After the...

Medigate Launches Clinical Device Efficiency to Improve Operational Efficiency for HDOs

The new offering from the medical device cybersecurity leader aims to increase medical device visibility, streamline hospital workflows, and reduce costs BROOKLYN, N.Y., Oct. 26, 2021 /PRNewswire/ -- Medigate, creator of the industry's first and leading healthcare-specific platform to orchestrate and integrate connected device data to improve network and IoT security, announced today...

Samsung Biologics Reports Third Quarter 2021 Financial Results

Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compared to Q3'20. Stable supply, strong operational excellence and a high utilization rate across all plants. Active investment on expansion, pre-sales activities of Plant 4 and ESG efforts to deliver the company's future growth plans....

Kontron Launches A New 3.5″ Single Board Computer To Help Developers Build An AI-enabled Embedded System

TAIPEI, Oct. 26, 2021 /PRNewswire/ -- Kontron, a leading global provider of IoT / Embedded Computing Technology, launches a new 3.5" single board computer, named 3.5"-SBC-TGL, powered by 11th Generation Intel® Core™ U-Series and Celeron® 6000 Series processors (Code Name: Tiger Lake UP3), to help system developers build a low-latency, graphics-demanding and AI-enabled embedded system for smart retail, industrial...

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818

JIAXING, China and BURLINGAME, Calif., Oct. 26, 2021 /PRNewswire/ -- Angel Pharmaceuticals Co., Ltd. ("Angel Pharma") today announced that its IND application for CPI-818, a small molecule ITK inhibitor, has been approved by the Center for Drug Evaluation (CDE) to initiate clinical trials in patients with relapsed/refractory T-cell lymphomas (TCL) in China. CPI-818, the first-and-only ITK inhibitor in...

Wellspring Capital Management Acquires Caring Brands International

SUNRISE, Fla., Oct. 25, 2021 /PRNewswire/ -- Wellspring Capital Management ("Wellspring"), a leading private equity firm headquartered in New York, announced today that it has partnered with management to complete the acquisition of Caring Brands International, Inc. ("CBI" or the "Company"). Terms of the transaction were not disclosed. Tracing its heritage back to 1966, CBI is the leading franchisor...